- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
Apr 22, 2020
QuEST Global Enhances its Lung Nodule Detection Solution Using Microsoft Azure IoT Central, Azure IoT Edge and Azure Machine Learning
Jun 12, 2020
QiSant™ Initial Publication Demonstrates Strong Clinical Validation of Urine-Based Assay in Kidney Transplant Surveillance
Mar 19, 2020
Chinese scientists seeking several potential COVID-19 treatment find 'extremely effective' antibodies
Apr 01, 2020
United Global Alliance Partners With Acumen Research Laboratories to Distribute Novel Coronavirus Diagnostic Test Kits
Apr 07, 2020
North America Anti-Viral Therapies Market Growth Focusing on Trends & Innovations During the Period Until 2027
Dec 18, 2020
Viracor Eurofins Launches Highly Accurate Antibody Tests for Coronavirus (COVID-19) SARS-CoV-2
May 08, 2020
Follow us on
